ADMA Biologics, Inc.
NASDAQ:ADMABiotechnology
+$0.04 today
- Market cap
- $2.96B
- Beta
- 0.73
- P/E (TTM)
- 12.1
- EPS (TTM)
- $0.70
Volume 3.62M
Average 7.07M
Balance Sheet
Inspect the capital base behind the business.
Assets
$624.24M
FY 2025 · Annual
+27.7% YoYLiabilities
$146.92M
FY 2025 · Annual
+5.2% YoYEquity
$477.32M
FY 2025 · Annual
+36.8% YoYBalance Sheet
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 51.09M | 86.52M | 51.35M | 103.15M | 87.63M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 28.58M | 15.51M | 27.42M | 50M | 158.43M |
| Inventory | 124.72M | 163.28M | 172.91M | 170.24M | 206.47M |
| Other Current Assets | 0 | 5.1M | 5.33M | 8.03M | 13.99M |
| Total Current Assets | 208.73M | 270.4M | 257.01M | 331.41M | 466.51M |
| Property, Plant & Equipment (Net) | 58.2M | 68.75M | 63.47M | 63.34M | 71.71M |
| Goodwill | 3.53M | 3.53M | 3.53M | 3.53M | 3.53M |
| Intangible Assets | 1.73M | 1.01M | 499K | 460K | 632K |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 84.28M | 73.26M |
| Other Non-current Assets | 4.07M | 4.77M | 4.67M | 5.66M | 8.6M |
| Total Non-current Assets | 67.52M | 78.06M | 72.17M | 157.27M | 157.73M |
| Total Assets | 276.25M | 348.46M | 329.18M | 488.68M | 624.24M |
| Account Payables | 12.43M | 13.23M | 15.66M | 20.22M | 22.52M |
| Short-term Debt | 0 | 0 | 0 | 0 | 2.81M |
| Tax Payables | 0 | 0 | 0 | 3.48M | 0 |
| Deferred Revenue | 142.83K | 143K | 182K | 143K | 0 |
| Other Current Liabilities | 16.05M | 1.8M | 2.37M | 1.85M | 6.82M |
| Total Current Liabilities | 30.38M | 39.27M | 49.81M | 55.54M | 69.54M |
| Long-term Debt | 94.87M | 142.83M | 130.59M | 72.34M | 69.33M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 1.98M | 1.83M | 1.69M | 1.55M | 1.41M |
| Other Non-current Liabilities | 397.35K | 1.85M | 2.11M | 1.67M | 0 |
| Total Non-current Liabilities | 104.7M | 157.22M | 144.17M | 84.12M | 77.38M |
| Total Liabilities | 135.08M | 196.49M | 193.98M | 139.66M | 146.92M |
| Common Stock | 19.58K | 22K | 23K | 24K | 24K |
| Retained Earnings | (412.11M) | (478.02M) | (506.26M) | (308.58M) | (161.65M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 141.17M | 151.97M | 135.21M | 349.02M | 477.32M |
| Total Debt | 102.92M | 154.44M | 141.42M | 82.12M | 79.89M |
| Net Debt | 51.83M | 67.92M | 90.07M | (21.03M) | (7.75M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $136.0M |
| Receivables | $138.2M |
| Inventory | $239.3M |
| Other Current | $14.6M |
| Total Current Assets | $528.2M |
| PP&E (Net) | $72.8M |
| Goodwill | $3.5M |
| Intangible Assets | $575.0K |
| Tax Assets | $70.0M |
| Other Non-current | $9.1M |
| Total Non-current Assets | $156.0M |
| Total Assets | $684.2M |
Analysis
Selected assets total $684.2M for Latest. The largest visible component is Inventory at $239.3M, about 35.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G | SC 13G filing | Nov 10, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 5, 2026 | |
| 10-Q | Quarterly report | Nov 4, 2026 | |
| 8-K | Current report | Nov 4, 2026 | |
| SC 13G | SC 13G filing | Aug 7, 2026 |
How much cash does ADMA have?
ADMA Biologics, Inc. (ADMA) reported $87.63M in cash and equivalents in fiscal 2025.
How much debt does ADMA carry?
ADMA Biologics, Inc. (ADMA) reported $79.89M of total debt, with net debt of -$7.75M.
Continue the stock analysis
Jump to another research area for this company.